Michael Mano

Insider Reports History

Location
Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Michael Mano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Mano:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP, CLO&Secretary Common Stock 97,490 $732,471 $7.51 31 Jan 2026 Direct
Karyopharm Therapeutics Inc. EVP, CLO&Secretary Stock Option (right to buy) 4,500 28 Feb 2025 Direct

Insider Reports Filed by Michael Mano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 31 Jan 2026 1 $0 4 EVP, CLO&Secretary 03 Feb 2026, 16:28
KPTI Karyopharm Therapeutics Inc. 15 Oct 2025 1 $0 4 SVP, General Counsel&Secretary 16 Oct 2025, 16:30
KPTI Karyopharm Therapeutics Inc. 12 Sep 2025 2 -$1,505 4 SVP, General Counsel&Secretary 16 Sep 2025, 16:34
KPTI Karyopharm Therapeutics Inc. 04 Mar 2025 1 -$17,568 4 SVP, General Counsel&Secretary 06 Mar 2025, 16:13
KPTI Karyopharm Therapeutics Inc. 28 Feb 2025 4 $0 4 SVP, General Counsel&Secretary 04 Mar 2025, 16:46
KPTI Karyopharm Therapeutics Inc. 04 Sep 2024 1 -$2,866 4 SVP, General Counsel&Secretary 05 Sep 2024, 16:28
KPTI Karyopharm Therapeutics Inc. 29 Feb 2024 2 -$24,150 4 SVP, General Counsel&Secretary 04 Mar 2024, 19:38
KPTI Karyopharm Therapeutics Inc. 28 Feb 2024 1 $0 4 SVP, General Counsel&Secretary 29 Feb 2024, 17:35
KPTI Karyopharm Therapeutics Inc. 24 Jan 2024 1 $0 4 SVP, General Counsel&Secretary 25 Jan 2024, 18:53
KPTI Karyopharm Therapeutics Inc. 01 Sep 2023 1 -$5,176 4 SVP, General Counsel&Secretary 05 Sep 2023, 16:29
KPTI Karyopharm Therapeutics Inc. 28 Feb 2023 2 -$20,835 4 SVP, General Counsel&Secretary 02 Mar 2023, 16:35
KPTI Karyopharm Therapeutics Inc. 31 Aug 2022 2 $0 4 SVP, General Counsel&Secretary 01 Sep 2022, 21:01
KPTI Karyopharm Therapeutics Inc. 28 Feb 2022 2 $0 4 SVP, General Counsel&Secretary 02 Mar 2022, 14:14